LiaoKFHwangBFLiuC, et al. Comment on Rotshild et al’s “The Risk for Prostate Cancer with Calcium Channel Blockers.”Ann Pharmacother.
2.
RotshildVRabkinNMatokI.The risk for prostate cancer with calcium channel blockers: a systematic review, meta-analysis, and meta-regression. Ann Pharmacother. 2023;57(1):16-28. doi:10.1177/10600280221098121
3.
UngerTBorghiCCharcharF, et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334-1357. doi:10.1161/HYPERTENSIONAHA.120.15026